Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study. (Q50207364)

From Wikidata

Jump to navigation Jump to search

scientific article published on 25 January 2018

Language	Label	Description	Also known as
English	Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study.	scientific article published on 25 January 2018

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29395999%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29395999%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29395999%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Mary Elizabeth Ramsay

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29395999%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Elizabeth Miller

8

object named as

Elizabeth Miller

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29395999%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

author name string

Shamez N Ladhani

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29395999%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Sarah Collins

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29395999%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Abdelmajid Djennad

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29395999%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Carmen L Sheppard

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29395999%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Nicholas J Andrews

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29395999%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Ray Borrow

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29395999%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

publication date

26 January 2018

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29395999%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Lancet Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29395999%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29395999%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29395999%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

441-451

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29395999%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Using the indirect cohort design to estimate the effectiveness of the seven valent pneumococcal conjugate vaccine in England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930052-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930052-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930052-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930052-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930052-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930052-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930052-5

7 January 2021

based on heuristic

inferred from DOI database lookup

10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930052-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Outbreaks of serious pneumococcal disease in closed settings in the post-antibiotic era: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930052-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased Invasive Pneumococcal Disease, North East England, UK.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930052-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Decrease of invasive pneumococcal disease (IPD) in adults after introduction of pneumococcal 13-valent conjugate vaccine in Spain.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930052-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The epidemiology of invasive pneumococcal disease in older adults in the post-PCV era. Has there been a herd effect?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930052-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930052-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930052-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of Childhood Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Adults With Underlying Comorbidities in Calgary, Alberta (2000-2013).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930052-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The herd effects of infant PCV7/PCV13 sequential implementation on adult invasive pneumococcal disease, six years post implementation; a nationwide study in Israel

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930052-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930052-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930052-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930052-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Pneumococcal conjugate vaccine failure in children: A systematic review of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930052-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930052-5

7 January 2021

based on heuristic

inferred from DOI database lookup

PCV13-vaccinated children still carrying PCV13 additional serotypes show similar carriage density to a control group of PCV7-vaccinated children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930052-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The Effects of Live Attenuated Influenza Vaccine on Nasopharyngeal Bacteria in Healthy 2 to 4 Year Olds. A Randomized Controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930052-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The cost-effectiveness of a 13-valent pneumococcal conjugate vaccination for infants in England

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930052-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1473-3099(18)30052-5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29395999%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29395999%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50207364&oldid=1417912326"